BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND RB1, OSRC, ENSG00000139687, 5925, RB, P06400 AND Treatment
115 results:

  • 1. Combination of minimal residual disease on day 15 and copy number alterations results in BCR-ABL1-negative pediatric B-ALL: A powerful tool for prediction of induction failure.
    Baghdadi H; Soleimani M; Zavvar M; Bahoush G; Poopak B
    Cancer Genet; 2024 Apr; 282-283():27-34. PubMed ID: 38183785
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Adding a Gene Expression Profile Test to Aid Differential Diagnosis and treatment in Aggressive Large B-Cell lymphoma: An Early Exploratory Economic Evaluation.
    Bouttell J; Fraser H; Goodlad JR; Hopkins D; McKay P; Oien KA; Seligmann B; von Delft S; Hawkins N
    Appl Health Econ Health Policy; 2024 Mar; 22(2):243-254. PubMed ID: 38017318
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma.
    Sloan SL; Brown F; Long M; Weigel C; Koirala S; Chung JH; Pray B; Villagomez L; Hinterschied C; Sircar A; Helmig-Mason J; Prouty A; Brooks E; Youssef Y; Hanel W; Parekh S; Chan WK; Chen Z; Lapalombella R; Sehgal L; Vaddi K; Scherle P; Chen-Kiang S; Di Liberto M; Elemento O; Meydan C; Foox J; Butler D; Mason CE; Baiocchi RA; Alinari L
    Blood; 2023 Sep; 142(10):887-902. PubMed ID: 37267517
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Impact of immunochemotherapy with R-bendamustine or R-CHOP for treatment naïve advanced-stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi.
    Nizzoli ME; Manni M; Ghiggi C; Pulsoni A; Musuraca G; Merli M; Califano C; Bari A; Massaia M; Conconi A; Musto P; Mannina D; Perrone T; Re F; Galimberti S; Gini G; Capponi M; Vitolo U; Usai SV; Stefani PM; Ballerini F; Liberati AM; Pennese E; Pastore D; Skrypets T; Catellani H; Marcheselli L; Federico M; Luminari S
    Hematol Oncol; 2023 Oct; 41(4):655-662. PubMed ID: 37246287
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A phase I study of the combination of palbociclib and dexamethasone for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia.
    Wilde L; Porazzi P; Trotta R; De Dominici M; Palmisiano N; Keiffer G; Rancani K; Yingling K; Calabretta B; Kasner M
    Leuk Res; 2023 Jun; 129():107075. PubMed ID: 37079999
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cytotoxic Effects of Darinaparsin, a Novel Organic Arsenical, against Human Leukemia Cells.
    Yuan B; Kikuchi H; Li J; Kawabata A; Yao K; Takagi N; Okazaki M
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768603
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [A Case of Malignant Rectal B Cell lymphoma That Was Difficult to Differentiate from Rectal Neuroendocrine Tumor].
    Murao S; Danno K; Nakamichi I; Takeda T; Fujino S; Takada N; Yamamoto K; Higashiguchi M; Noguchi K; Toyoda Y; Nakane S; Yamamoto H; Hirao T; Oka Y
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1793-1795. PubMed ID: 36733001
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Evaluation of 4 prognostic indices in follicular lymphoma treated in first line with immunochemotherapy.
    Rodríguez-Sevilla JJ; Fernández-Rodríguez C; Bento L; Diez-Feijóo R; Pinzón S; Gibert J; Fernández-Ibarrondo L; Lafuente M; Ferrer A; Sánchez-González B; Gimeno E; Sainz J; Ramos R; García JF; Colomo L; Bellosillo B; Gutiérrez A; Salar A
    Blood Adv; 2023 Apr; 7(8):1606-1614. PubMed ID: 36260737
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Targeted treatment and Immunotherapy in High-risk and Relapsed/ Refractory Pediatric Acute Lymphoblastic Leukemia.
    Graiqevci-Uka V; Behluli E; Spahiu L; Liehr T; Temaj G
    Curr Pediatr Rev; 2023; 19(2):150-156. PubMed ID: 36056858
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma.
    Villa D; Hoster E; Hermine O; Klapper W; Szymczyk M; Bosly A; Unterhalt M; Rimsza LM; Ramsower CA; Freeman CL; Scott DW; Gerrie AS; Savage KJ; Sehn LH; Dreyling M
    Blood Adv; 2022 Sep; 6(18):5285-5294. PubMed ID: 35439293
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. ATPR regulates human mantle cell lymphoma cells differentiation via SOX11/CyclinD1/Rb/E2F1.
    Xu X; Zhang T; Zhang M; Li L; Deng G; Lu Z; Zhang Z; Du Y; Feng Y; Feng X; Peng X; Chen F
    Cell Signal; 2022 May; 93():110280. PubMed ID: 35151831
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [IgG-variant Bing-Neel syndrome diagnosed by detecting MYD88 L265P mutation in the cerebrospinal fluid cells].
    Maruyama Y; Nishikii H; Matsuoka R; Makishima K; Kurita N; Kusakabe M; Yokoyama Y; Kato T; Sakata-Yanagimoto M; Obara N; Nakamura N; Chiba S
    Rinsho Ketsueki; 2021; 62(10):1493-1498. PubMed ID: 34732622
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Pre-treatment health-related quality of life parameters have prognostic impact in patients >65 years with newly diagnosed mantle cell lymphoma: The Nordic lymphoma Group MCL4 (LENA-BERIT) experience.
    Lindberg Å; Eskelund CW; Albertsson-Lindblad A; Kolstad A; Laurell A; Räty R; Grønbaek K; Geisler CH; Jerkeman M
    Hematol Oncol; 2022 Feb; 40(1):22-30. PubMed ID: 34713465
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Feasibility of Combining the Phosphatidylinositol 3-Kinase Inhibitor Copanlisib With Rituximab-Based Immunochemotherapy in Patients With Relapsed Indolent B-cell lymphoma.
    Matasar MJ; Dreyling M; Leppä S; Santoro A; Pedersen M; Buvaylo V; Fletcher M; Childs BH; Zinzani PL
    Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):e886-e894. PubMed ID: 34389273
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Proposal and clinical application of molecular genetic risk scoring system, "MRplus", for BCR-ABL1 negative pediatric B-cell acute lymphoblastic leukemia- report from a single centre.
    Gupta SK; Bakhshi S; Kamal VK; Gupta R; Sharma P; Pushpam D; Sahoo RK; Sharma A
    Leuk Res; 2021 Dec; 111():106683. PubMed ID: 34371436
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Coexistence of a secondary STRN-ALK, EML4-ALK double-fusion variant in a lung adenocarcinoma patient with EGFR mutation: a case report.
    Zeng Q; Gao H; Zhang L; Qin S; Gu Y; Chen Q
    Anticancer Drugs; 2021 Sep; 32(8):890-893. PubMed ID: 34232939
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [A Case of Diffuse Large B-Cell lymphoma of the Testis, Which Also Developed in the Rectum after Resection of a Large B-Cell lymphoma].
    Tsurui K; Sumi T; Mimuro A; Tachibana S; Matsudo T; Sahara Y; Kuboyama Y; Fukushima G; Ishibashi Y
    Gan To Kagaku Ryoho; 2021 Feb; 48(2):303-305. PubMed ID: 33597389
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Long-term follow-up after rituximab plus bendamustine in a patient with relapsed or refractory hairy cell leukemia variant: A case report.
    Imoto N; Koyama D; Sugiura I; Kurahashi S
    Medicine (Baltimore); 2021 Feb; 100(5):e24457. PubMed ID: 33592897
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with Prognosis.
    Hosein Pour Feizi A; Zeinali S; Toporski J; Sheervalilou R; Mehranfar S
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3493-3500. PubMed ID: 33369444
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Surveilling Russell body
    Peruhova M; Peshevska-Sekulovska M; Georgieva V; Panayotova G; Dikov D
    World J Gastroenterol; 2020 Sep; 26(33):5050-5059. PubMed ID: 32952348
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.